+

WO1995033845A1 - Process for producing optically active propargyl alcohol compound - Google Patents

Process for producing optically active propargyl alcohol compound Download PDF

Info

Publication number
WO1995033845A1
WO1995033845A1 PCT/JP1995/001064 JP9501064W WO9533845A1 WO 1995033845 A1 WO1995033845 A1 WO 1995033845A1 JP 9501064 W JP9501064 W JP 9501064W WO 9533845 A1 WO9533845 A1 WO 9533845A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
carbon atoms
formula
optically active
alkyl group
Prior art date
Application number
PCT/JP1995/001064
Other languages
French (fr)
Japanese (ja)
Inventor
Kazuya Kameo
Tohru Tanami
Hideo Tanaka
Yohichi Shimazaki
Masaru Mutoh
Mie Tsuboi
Naoya Ono
Katsuo Hatayama
Original Assignee
Taisho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co., Ltd. filed Critical Taisho Pharmaceutical Co., Ltd.
Priority to AU25752/95A priority Critical patent/AU2575295A/en
Publication of WO1995033845A1 publication Critical patent/WO1995033845A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters

Definitions

  • the present invention relates to an optically active propargyl alcohol compound and a method for producing an acylated product thereof.
  • optically active propargyl alcohol compounds and their acylated compounds are important as synthetic intermediates for various biologically active substances.
  • methods for producing optically active propargyl alcohol include (1) a method of optically reducing ketones (Gooding OW et al., J. Org. Chem., Vol. 58, p. 368, page 1). (2) Method for synthesis from 2,3-0-isopropylidene-slate (Niidas P. et al., Eesti NSV Tead Akad. Toim., Keem., Vol. 38 ( 4), pp. 285-6, 1989).
  • An object of the present invention is to provide a simpler method for producing an optically active propargyl alcohol compound having excellent optical purity and an acylated product thereof. Disclosure of the invention
  • the present inventors have conducted intensive studies for the purpose of solving the above-mentioned problems, and as a result, by stereoselectively acylating a racemic propargyl alcohol compound using an enzyme, a high purity and a high yield of the optically active compound are obtained.
  • the present inventors have found that a propargyl alcohol compound can be produced, and have completed the present invention.
  • R 1 and R 2 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms
  • R 3 represents a phenyl group, a ⁇ alkynol group having 1 to 5 carbon atoms, a halogen atom, a trifluoromethyl group
  • R 4 represents an alkyl group having 1 to 10 carbon atoms
  • the * symbol indicates that the compound is optically active.
  • a Lugyl alcohol compound is reacted in the presence of an enzyme with an acylating agent represented by the formula R 4 COOR (where R 4 has the same meaning as described above, and R represents any alkynole or alkenyl group).
  • R 4 has the same meaning as described above, and R represents any alkynole or alkenyl group.
  • a method for producing an optically active 0-acylpropargyl alcohol compound represented by the formula (1) characterized by comprising:
  • Another aspect of the present invention provides a method of formula (3), comprising separating an optically active 0-acylpropargyl alcohol compound of the formula (1) from the reaction solution after the above reaction, and hydrolyzing the compound.
  • Another aspect of the present invention is to provide an optically active compound, comprising separating an optically active pergyl alcohol compound having a steric configuration different from that of the compound of the formula (3) from the reaction solution after the reaction. This is a method for producing a propargyl alcohol compound.
  • the halogen atom is a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
  • the alkyl group having 1 to 3 carbon atoms is a chain or branched alkyl group, for example, a methyl group, an ethyl group, and an isopropyl group. Of these, a methyl group or an ethyl group is preferred.
  • the alkyl group having 1 to 5 carbon atoms is a chain or branched alkyl group, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a pentyl group, and an isopentyl group. .
  • An alkyl group having 1 to 8 carbon atoms is a chain or branched alkyl group, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, and the like.
  • An alkyl group having 1 to 10 carbon atoms is a chain or branched alkyl group, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a pentyl group, a Examples include a sopentyl group, a hexyl group, an isohexyl group, a heptyl group, and an isoheptyl group. Among them, preferred are a methyl group, an ethyl group, a propyl group, an isopropyl group and a butyl group.
  • Examples of the cycloalkyl group having 5 to 8 carbon atoms include a cyclopentyl group, a cyclohexyl group, a cycloheptyl group and the like.
  • the arbitrary alkyl group or alkenyl group represented by R may be any group which does not affect the reaction at all, for example, a methyl group, an ethyl group, a propynole group, an isopropyl group, a butyl group Group, isobutyl group, pentyl group, isopentyl group, hexyl group, isohexyl group, heptyl group, isoheptyl group, vinyl group, aryl group, 1-propenyl group, 2-buteninole group, isopropyl group And so on.
  • the enzyme used in the present invention refers to an optically active 0-acylpropargyl alcohol compound of the formula (1) formed from a (RS) -proparginole alcohol compound of the formula (2)
  • An enzyme having the activity of causing Preferred is an enzyme produced by a microorganism belonging to the genus Pseudomonas, and more preferred is lipase PS (Amano Pharmaceutical).
  • vinyl acetate, isopropenylpropionate, or isopropenylbenzoate can be used as the acylating agent, and is preferably isoprobenyl acetate.
  • Prono of the above formula (2) which is a raw material.
  • the racemic form of lugyl alcohol can be easily obtained, for example, by reacting the corresponding aldehyde form (4) with the acetylene Grignard reagent (5) as shown below (in the reaction formula, RR 2 and R 3 are as defined above, and X represents a bromo or chloro atom.
  • reaction with isopropenyl acetate is carried out by adding 0.1 to 50 times by weight of the enzyme and 1 to 50 parts by weight of the racemic propargyl alcohol of the formula (2).
  • the reaction is carried out in an inert solvent at 0 to 50 ° C. using 100 equivalents.
  • the inert solvent include methylene chloride, toluene, ether, t-butyl methyl ether and the like.
  • the reaction time varies considerably depending on the substrate, the reaction temperature and the amount of the enzyme, and varies from as little as one hour to several days, and is it possible to obtain the preferred isomer as an acetyl form? It is desirable to adjust as appropriate depending on whether the alcohol is obtained as unreacted alcohol. In the former case, it is preferable to keep the reaction rate at 50% or less, and in the latter case, conversely, when the reaction rate is raised to 50% or more, a compound with good optical purity can be obtained.
  • the obtained alcohol form was prepared according to the method of Niidas P. et al. (Eesti NSV Tead Akad. Toim., Keem., Volume 38 (4 ), Pp. 285-6, 1989), and confirmed to be S-form.
  • Example 2 The same operation as in (1) of Example 2 was performed using (3RS) —3-hydroxy-4,4-dimethyl-4-pentoxy-1-butyne obtained by the same method as in Example 1.
  • the present invention is useful as a simpler method for producing an optically active propargyl alcohol compound having a higher optical purity and an acylated product thereof.
  • optically active propargyl alcohol compounds and their acylated compounds are important as intermediates for the synthesis of various physiologically active substances, but are particularly important as intermediates for the synthesis of the ⁇ side chain of prostaglandin derivatives useful as pharmaceuticals. is there.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for stereoselectively obtaining an optically active O-acylpropargyl alcohol compound represented by general formula (2) (wherein R?1 and R2¿ represent each hydrogen or C¿1?-C3 alkyl; R?3¿ represents phenyl which may be substituted by C¿1?-C5 alkyl, halogeno or trifluoromethyl at an arbitrary position of the ring, C1-C8 alkyl or C5-C8 cycloalkyl; R?4¿ represents C¿1?-C10 alkyl or phenyl which may be substituted by phenyl or halogeno at an arbitrary position of the ring; and the asterisk represents optical activity) by the reaction of an (RS)-propargyl alcohol compound represented by general formula (1) (wherein R?1, R2 and R3¿ are each as defined above) with an acylating agent R4COOR (wherein R4 is as defined above; and R represents arbitrary alkyl or alkenyl) in the presence of an enzyme; and a process for obtaining an optically active propargyl alcohol compound either by hydrolyzing the above O-acyl compound or from the solution of the above acylation reaction.

Description

- 1 ― 明 細 書 光学活性プロパルギルアルコール化合物の製造方法 技術分野  -1 ― Description Method for producing optically active propargyl alcohol compound
本発明は、 光学活性プロパルギルアルコ一ル化合物及びそのァシル化体の製造 方法に関す ¾。  The present invention relates to an optically active propargyl alcohol compound and a method for producing an acylated product thereof.
これら光学活性プロパルギルアルコール化合物及びそのァシル化体は種々の生 理活性物質の合成中間体として重要であるが、 特に医薬品として有用なプロスタ  These optically active propargyl alcohol compounds and their acylated compounds are important as synthetic intermediates for various biologically active substances.
'誘導体の ω側鎖の合成中間体として重要である。 背景技術 'It is important as a synthetic intermediate of the ω side chain of the derivative. Background art
従来、 光学活性プロパルギルアルコールの製造法としては、 ( 1 ) ケ卜ン体を 光学選択的に還元する方法 (Gooding O. W.ら, J. Org. Chem. , 第 5 8巻, 第 3 6 8 1頁, 1 9 9 3年) ; (2 ) 2 , 3— 0—イソプロピリデン—スレイト一ルから合 成する方法 (Niidas P.ら, Eesti NSV Tead Akad. Toim. , Keem. , 第 3 8巻(4 ) , 第 2 8 5〜6頁, 1 9 8 9年) 等が知られている。  Conventionally, methods for producing optically active propargyl alcohol include (1) a method of optically reducing ketones (Gooding OW et al., J. Org. Chem., Vol. 58, p. 368, page 1). (2) Method for synthesis from 2,3-0-isopropylidene-slate (Niidas P. et al., Eesti NSV Tead Akad. Toim., Keem., Vol. 38 ( 4), pp. 285-6, 1989).
しかしながら、 従来の方法は工程数が多く適切な方法とはいえない。 本発明は、 より簡便で光学純度に優れた光学活性プロパルギルアルコール化合物及びそのァ シル化体の製造方法を提供することを目的とする。 発明の開示  However, the conventional method has many steps and cannot be said to be an appropriate method. An object of the present invention is to provide a simpler method for producing an optically active propargyl alcohol compound having excellent optical purity and an acylated product thereof. Disclosure of the invention
本発明者らは、 前記課題の解決を目的として鋭意研究を進めた結果、 ラセミ体 のプロパルギルアルコール化合物を酵素を用いて立体選択的にァシル化すること により高純度にて高収率で光学活性プロパルギルアルコール化合物が製造できる ことを見いだし、 本発明を完成した。  The present inventors have conducted intensive studies for the purpose of solving the above-mentioned problems, and as a result, by stereoselectively acylating a racemic propargyl alcohol compound using an enzyme, a high purity and a high yield of the optically active compound are obtained. The present inventors have found that a propargyl alcohol compound can be produced, and have completed the present invention.
即ち、 本発明は、 式 ( 1 )
Figure imgf000004_0001
That is, the present invention provides the following formula (1):
Figure imgf000004_0001
(式中、 R 1及び R 2はそれぞれ水素原子又は炭素原子数 1〜 3のアルキル基を示 し、 R3はフヱニル基、 「炭素原子数 1〜 5のアルキノレ基、 ハロゲン原子、 トリフ ルォロメチル基」 で任意の位置を置換されたフヱニル基、 炭素原子数:!〜 8のァ ルキル基又は炭素原子数 5 ~ 8のシクロアルキル基を示し、 R 4は炭素原子数 1〜 10のアルキル基、 フヱニル基、 「フヱニル基又はハロゲン原子」 で任意の位置 を置換されたフユ二ル基を示し、 言己号 *は光学活性であることを示す。 ) で表さ れる光学活性〇一ァシルプロパルギルアルコール化合物を製造するにあたり、 式(Wherein, R 1 and R 2 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 3 represents a phenyl group, a `` alkynol group having 1 to 5 carbon atoms, a halogen atom, a trifluoromethyl group, Represents a phenyl group substituted at an arbitrary position by the above, a carbon atom number: an alkyl group having 8 to 8 carbon atoms or a cycloalkyl group having 5 to 8 carbon atoms, R 4 represents an alkyl group having 1 to 10 carbon atoms, A phenyl group or a phenyl group substituted at an arbitrary position with a “phenyl group or a halogen atom”, and the * symbol indicates that the compound is optically active. In producing an alcohol compound, the formula
(2) (2)
Figure imgf000004_0002
Figure imgf000004_0002
(式中、 R1 R2及び R3は前記と同意義である。 ) で表される (RS) —プロノ、。 ルギルアルコール化合物を酵素存在下、 式 R4COOR (式中、 R4は前記と同意 義であり、 Rは任意のアルキノレ基又はアルケニル基を示す。 ) で表されるァシル 化剤と反応させることを特徴とする式 (1) の光学活性 0—ァシルプロパルギル アルコール化合物の製造方法である。 また、 他の本発明は、 上記の反応後、 反応 液より式 (1) の光学活性 0—ァシルプロパルギルアルコール化合物を分離し、 これを加水分解することを特徴とする式 (3) (Wherein R 1 R 2 and R 3 have the same meanings as described above.). A Lugyl alcohol compound is reacted in the presence of an enzyme with an acylating agent represented by the formula R 4 COOR (where R 4 has the same meaning as described above, and R represents any alkynole or alkenyl group). A method for producing an optically active 0-acylpropargyl alcohol compound represented by the formula (1), characterized by comprising: Another aspect of the present invention provides a method of formula (3), comprising separating an optically active 0-acylpropargyl alcohol compound of the formula (1) from the reaction solution after the above reaction, and hydrolyzing the compound.
Figure imgf000004_0003
Figure imgf000004_0003
(式中、 、 R R3及び *は前記と同意義である。 ) で表される光学活性プロ ノ、。ノレギルアルコール化合物の製造方法である。 さらに、 他の本発明は、 上記の反 応後、 反応液より前記式 (3 ) の化合物とは異なる立体配位を有する光学活性プ 口パルギルアルコール化合物を分離することを特徴とする光学活性プロパルギル アルコール化合物の製造方法である。 (Wherein, RR 3 and * have the same meanings as described above.) No ,. This is a method for producing a noregyl alcohol compound. Furthermore, another aspect of the present invention is to provide an optically active compound, comprising separating an optically active pergyl alcohol compound having a steric configuration different from that of the compound of the formula (3) from the reaction solution after the reaction. This is a method for producing a propargyl alcohol compound.
本発明において、 ハロゲン原子とはフッ素原子、 塩素原子、 臭素原子及びヨウ 素原子である。 炭素原子数 1〜 3のアルキル基とは鎖状又は分枝鎖状のアルキル 基であり、 たとえばメチル基、 ェチル基、 イソプロピル基である。 このうち好ま しくは、 メチル基又はェチル基である。 炭素原子数 1〜 5のアルキル基とは鎖状 又は分枝鎖状のアルキル基であり、 たとえばメチル基、 ェチル基、 プロピル基、 イソプロピル基、 ブチル基、 イソブチル基、 ペンチル基、 イソペンチル基である。 このうち好ましくは、 メチル基、 ェチル基、 プロピル基、 イソプロピル基又はブ チル基である。 炭素原子数 1〜 8のアルキル基とは鎖状又は分枝鎖状のアルキル 基であり、 たとえばメチル基、 ェチル基、 プロピル基、 イソプロピル基、 ブチル 基、 イソブチル基、 ペンチル基、 イソペンチル基、 へキシル基、 イソへキシノレ基、 ヘプチル基、 イソへプチル基などである。 このうち好ましくは、 メチル基、 ェチ ル基、 プロピル基、 イソプロピル基又はブチル基である。 炭素原子数 1〜 1 0の アルキル基とは鎖状又は分枝鎖状のアルキル基であり、 たとえばメチル基、 ェチ ル基、 プロピル基、 イソプロピル基、 ブチル基、 イソブチル基、 ペンチル基、 ィ ソペンチル基、 へキシル基、 イソへキシル基、 ヘプチル基、 イソへプチル基など である。 このうち好ましくは、 メチル基、 ェチル基、 プロピル基、 イソプロピル 基又はブチル基である。 炭素原子数 5〜 8のシクロアルキル基とは、 たとえばシ クロペンチル基、 シクロへキシル基、 シクロへプチル基などである。 Rで示され る任意のアルキル基又はアルケニル基とは、 反応に何等影響を及ぼさない基であ ればいずれであってもよく、 たとえばメチル基、 ェチル基、 プロピノレ基、 イソプ 口ピル基、 ブチル基、 イソブチル基、 ペンチル基、 イソペンチル基、 へキシル基、 イソへキシル基、 ヘプチル基、 イソへプチル基、 ビニル基、 ァリル基、 1一プロ ぺニル基、 2—ブテニノレ基、 イソプロぺニル基などである。  In the present invention, the halogen atom is a fluorine atom, a chlorine atom, a bromine atom and an iodine atom. The alkyl group having 1 to 3 carbon atoms is a chain or branched alkyl group, for example, a methyl group, an ethyl group, and an isopropyl group. Of these, a methyl group or an ethyl group is preferred. The alkyl group having 1 to 5 carbon atoms is a chain or branched alkyl group, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a pentyl group, and an isopentyl group. . Among them, preferred are a methyl group, an ethyl group, a propyl group, an isopropyl group and a butyl group. An alkyl group having 1 to 8 carbon atoms is a chain or branched alkyl group, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, and the like. Xyl, isohexynole, heptyl and isoheptyl groups. Of these, a methyl group, an ethyl group, a propyl group, an isopropyl group or a butyl group is preferred. An alkyl group having 1 to 10 carbon atoms is a chain or branched alkyl group, for example, a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a pentyl group, a Examples include a sopentyl group, a hexyl group, an isohexyl group, a heptyl group, and an isoheptyl group. Among them, preferred are a methyl group, an ethyl group, a propyl group, an isopropyl group and a butyl group. Examples of the cycloalkyl group having 5 to 8 carbon atoms include a cyclopentyl group, a cyclohexyl group, a cycloheptyl group and the like. The arbitrary alkyl group or alkenyl group represented by R may be any group which does not affect the reaction at all, for example, a methyl group, an ethyl group, a propynole group, an isopropyl group, a butyl group Group, isobutyl group, pentyl group, isopentyl group, hexyl group, isohexyl group, heptyl group, isoheptyl group, vinyl group, aryl group, 1-propenyl group, 2-buteninole group, isopropyl group And so on.
本発明に用いられる酵素とは、 式 (2 ) の (R S ) —プロパルギノレアルコール 化合物から式 (1 ) の光学活性 0—ァシルプロパルギルアルコール化合物を生成 させる活性を有する酵素である。 好ましくはシユードモナス属に属する微生物が 生産する酵素であり、 さらに好ましくはリパーゼ P S (天野製薬) である。 また、 ァシル化剤としてはビニルアセテート、 イソプロぺニルプロピオネート、 イソプ 口ぺニルベンゾエートを用いることができる力く、 好ましくはィソプロべ二ルァセ テ一卜である。 The enzyme used in the present invention refers to an optically active 0-acylpropargyl alcohol compound of the formula (1) formed from a (RS) -proparginole alcohol compound of the formula (2) An enzyme having the activity of causing Preferred is an enzyme produced by a microorganism belonging to the genus Pseudomonas, and more preferred is lipase PS (Amano Pharmaceutical). Further, vinyl acetate, isopropenylpropionate, or isopropenylbenzoate can be used as the acylating agent, and is preferably isoprobenyl acetate.
以下、 本発明について詳しく説明する。 ただし、 ァシル化剤としてイソプロべ ニルアセテートを用いた場合について説明する。  Hereinafter, the present invention will be described in detail. However, the case where isoprobenyl acetate is used as the acylating agent will be described.
原料である前記式 (2 ) のプロノ、。ルギルアルコールのラセミ体は、 例えば以下 に示すように、 対応するアルデヒド体 (4 ) を原料としてアセチレングリニャ一 ノレ試薬 (5 ) と反応することにより容易に得ることができる (反応式中、 R R 2及び R 3は前記と同意義であり、 Xはブロム又はクロル原子を示す。 ) 。 Prono of the above formula (2), which is a raw material. The racemic form of lugyl alcohol can be easily obtained, for example, by reacting the corresponding aldehyde form (4) with the acetylene Grignard reagent (5) as shown below (in the reaction formula, RR 2 and R 3 are as defined above, and X represents a bromo or chloro atom.
Figure imgf000006_0001
Figure imgf000006_0001
( ) ( 2 ) イソプロぺニルアセテートとの反応は、 原料の式 (2 ) のプロパルギルアルコ ールのラセミ体に対し、 酵素を 0. 1 ~ 5 0倍重量部、 イソプロぺニルアセテート を 1〜 1 0 0当量を用い 0〜 5 0 °Cにて、 不活性溶媒中で反応する。 不活性溶媒 としては、 塩化メチレン、 トルエン、 エーテル、 t一ブチルメチルエーテルなど 力く挙げられる。  () (2) The reaction with isopropenyl acetate is carried out by adding 0.1 to 50 times by weight of the enzyme and 1 to 50 parts by weight of the racemic propargyl alcohol of the formula (2). The reaction is carried out in an inert solvent at 0 to 50 ° C. using 100 equivalents. Examples of the inert solvent include methylene chloride, toluene, ether, t-butyl methyl ether and the like.
反応時間は、 基質、 反応温度、 酵素の量によりかなり異なり、 1時間以内で終 了するものから数日を要するものまで様々であり、 また好ましい異性体が、 ァセ チル体として得られるか、 未反応のアルコールとして得られるかにより適宜調節 することが望ましい。 前者の場合は、 反応率を 5 0 %以下に押さえた方が好まし く、 後者の場合は逆に反応率を 5 0 %以上に上げた方が光学純度のよい化合物が 得られる。  The reaction time varies considerably depending on the substrate, the reaction temperature and the amount of the enzyme, and varies from as little as one hour to several days, and is it possible to obtain the preferred isomer as an acetyl form? It is desirable to adjust as appropriate depending on whether the alcohol is obtained as unreacted alcohol. In the former case, it is preferable to keep the reaction rate at 50% or less, and in the latter case, conversely, when the reaction rate is raised to 50% or more, a compound with good optical purity can be obtained.
反応終了後は、 一般に用いられる方法、 即ち酵素を濾去し、 溶媒を濃縮の後、 シリカゲルカラムクロマトグラフィー、 蒸留、 再結晶等により容易にァセチル体 とアルコール体を分離精製することができる。 ァセチル体は、 エステルを加水分 解する通常の方法で容易に加水分解されアルコーノレ体に導くことができる。 発明を実施するための最良の形態 After completion of the reaction, a commonly used method is used, that is, the enzyme is filtered off, the solvent is concentrated, The acetyl and alcohol forms can be easily separated and purified by silica gel column chromatography, distillation, recrystallization, etc. The acetyl group can be easily hydrolyzed by an ordinary method for hydrolyzing an ester to lead to an alcoholic body. BEST MODE FOR CARRYING OUT THE INVENTION
以下、 実施例を挙げて本発明をさらに詳細に説明する。  Hereinafter, the present invention will be described in more detail with reference to Examples.
実施例 1  Example 1
(3RS) — 3—ヒドロシー 4一フエノキシ一 1ーブチンの製造法  (3RS) — 3-Hydrosea 4-phenoxy-1-butyne
アルゴン気流下、 フエノキシァセトアルデヒド (1 1. 16 g) のテトラヒドロ フラン (THF) 溶液 ( 1 6 Om 1 ) に、 氷冷下、 0.5Mェチニルマグネシウム プロマイドの THF溶液 (1 97m l ) を加え、 同温にて 1 0分間撹拌した。 反 応液に飽和アンモニゥム水溶液を加え、 エーテルにて抽出した。 有機層を水、 飽 和食塩水にて洗浄、 乾燥後、 濃縮し、 得られた粗成生物をシリカゲルカラムクロ マトグラフィー [展開溶媒;酢酸ェチル (A c OE t) :へキサン = 1 : 2] に て精製し標記化合物 (1 3.2 g) を得た。  Under a stream of argon, a solution of phenoxyacetaldehyde (11.16 g) in tetrahydrofuran (THF) (16 Om 1) and 0.5 M ethynylmagnesium bromide in THF (197 ml) were added under ice-cooling. Was added and stirred at the same temperature for 10 minutes. A saturated aqueous ammonium solution was added to the reaction solution, and the mixture was extracted with ether. The organic layer was washed with water and saturated saline, dried and concentrated, and the resulting crude product was subjected to silica gel column chromatography [developing solvent: ethyl acetate (AcOEt): hexane = 1: 2]. The title compound (13.2 g) was obtained.
Ή-NMR (CD C 13, 200 MHz) 5 p pm;  Ή-NMR (CD C 13, 200 MHz) 5 p pm;
2.53(d, J=2.3Hz, 1H), 2.56(d, J=5.4Hz, 1H), 4.03-4.21 (m, 2H), 4.70-4.83(m, 1H), 6.88-7.04(m, 3H), 7.23-7.36(m, 2H)  2.53 (d, J = 2.3Hz, 1H), 2.56 (d, J = 5.4Hz, 1H), 4.03-4.21 (m, 2H), 4.70-4.83 (m, 1H), 6.88-7.04 (m, 3H) , 7.23-7.36 (m, 2H)
I R (n e a t) cm— 1 : IR (neat) cm— 1 :
3412, 3282, 2940, 2865, 2126, 1602, 1589, 1499, 1456 1327, 1309, 1295, 1254, 1173, 1082, 1049, 969, 895, 752, 693, 674  3412, 3282, 2940, 2865, 2126, 1602, 1589, 1499, 1456 1327, 1309, 1295, 1254, 1173, 1082, 1049, 969, 895, 752, 693, 674
実施例 2  Example 2
' (3 R) —、 及び (3 S) — 3—ヒドロキシ一 4—フヱノキシー 1—ブチンの 製造法  '(3 R) — and (3 S) — Process for the production of 3-hydroxy-14-phenoxy-1-butyne
( 1 ) 実施例 1で得た ( 3 R S ) — 3—ヒドロキシ一 4一フエノキシ了 1—ブ チン (300mg) のトルエン溶液 (1 0m l ) にイソプロぺニルァセテ一ト (1. 5m l ) を加えさらにリパーゼ P S ( 1. 0 g) を加えて、 35°Cにて 1 2 時間撹拌した。 不溶物をろ過し、 減圧下溶媒濃縮後、 残渣をシリカゲルクロマト グラフィ一に付し、 Ac OE t— n へキサン (1 : 1 0) 流出分よりァセチル 体 (19 Omg) を得、 AcOE t— n—へキサン (1 : 5) 流出分より未反応 アルコール体 ( 13 Omg) を得た。 (1) Isopropenyl acetate (1.5 ml) was added to a toluene solution (10 ml) of (3RS) —3-hydroxy-41-phenoxy obtained in Example 1 and 1-butyne (300 mg). In addition, lipase PS (1.0 g) was further added, and the mixture was stirred at 35 ° C for 12 hours. After filtering the insoluble matter and concentrating the solvent under reduced pressure, the residue was subjected to silica gel chromatography to obtain acetyl from the effluent of AcOEt-n hexane (1:10). An unreacted alcohol form (13 Omg) was obtained from the effluent of AcOEt-n-hexane (1: 5).
アルコール体の [ ] D 23 =— 26.9 Γ (C = 0.9, クロ口ホルム) 得られたアルコール体は、 Niidas P.らの方法 (Eesti NSV Tead Akad. Toim. , Keem. , 第 38巻 (4) , 第 285~6頁, 1989年) で合成した化合物と比較 し、 S体であることを確認した。 Alcohol form [] D 23 = — 26.9 C (C = 0.9, black form) The obtained alcohol form was prepared according to the method of Niidas P. et al. (Eesti NSV Tead Akad. Toim., Keem., Volume 38 (4 ), Pp. 285-6, 1989), and confirmed to be S-form.
また、 純度は、 液体クロマトグラフィー (ODセル (ダイセル工業) 、 展開溶 媒;イソプロピルアルコール:へキサン = 2 : 8) にて測定 (98%e e) した。  The purity was measured (98% e e) by liquid chromatography (OD cell (Daicel Industries), developing solvent; isopropyl alcohol: hexane = 2: 8).
(2) (1) で得られたァセチル体 (19 Omg) [a] D 23 =— 40.8 ° (C = 0.93, メタノール) をメタノール (10m 1 ) に溶解し、 炭酸カリウム (13 Omg) を加え室温にて 20分間撹拌した。 3 N塩酸にて中和した後、 ェ —テルにて抽出した。 有機層を飽和重曹水、 飽和食塩水にて洗浄、 乾燥の後濃縮 し、 残渣をシリカゲルクロマトグラフィーに付し、 AcOE t— n—へキサン (1 : 10)流出分よりァセチル体 (19 Omg) を得、 A c 0 E t— n—へキ サン (1 : 5) 流出分より未反応アルコール体 (13 Omg) (96%e e) を 得た。 (2) Dissolve the acetyl group (19 Omg) obtained in (1) [a] D 23 = — 40.8 ° C (C = 0.93, methanol) in methanol (10 m 1) and add potassium carbonate (13 Omg). The mixture was stirred at room temperature for 20 minutes. After neutralization with 3N hydrochloric acid, the mixture was extracted with ether. The organic layer was washed with saturated aqueous sodium hydrogen carbonate and saturated brine, dried and concentrated. The residue was subjected to silica gel chromatography, and the acetyl compound (19 Omg) was obtained from the AcOEt-n-hexane (1:10) effluent. The unreacted alcohol (13 Omg) (96% ee) was obtained from the effluent of Ac0Et-n-hexane (1: 5).
これは、 (1) と同様にして R体であることを確認した。  This was confirmed to be R-form in the same way as (1).
以下の実施例の化合物における絶対配位は、 モッシャ一らの方法 (J. Am. Chem. 30。., 第95卷, 512ページ, 1973年) に基づき ーメ トキシー α—トリ フロロメチルフヱニル酢酸エステル (ΜΤΡΑエステル) に導き、 NMRにより fifet.した  Absolute coordination in the compounds of the following examples is based on the method of Mosher et al. (J. Am. Chem. 30., Vol. 95, p. 512, 1973). Nylacetic acid ester () ester) led to fifet. By NMR
実施例 3  Example 3
' (3 R) 一、 及び (3 S) — 3—ヒドロキシ一 4, 4一ジメチルー 4一フエノキ シー 1ーブチンの製造法  '(3R) mono- and (3 S)-3-Hydroxy- 1, 4, 4-dimethyl- 4-phenoxy 1
(1) 実施例 1と同様の方法で得られた (3RS) — 3—ヒドロキシー 4, 4— ジメチルー 4—フヱノキシー 1ーブチンを用い、 実施例 2の (1) と同様の操作 (1) The same operation as in (1) of Example 2 was performed using (3RS) —3-hydroxy-4,4-dimethyl-4-pentoxy-1-butyne obtained by the same method as in Example 1.
(35 、 20時間) にて、 (3 S) — 3—ヒドロキシー 4, 4一ジメチルー 4一 フエノキシ—1ーブチン (47%, 87%e e) 、 及び (3R) — 3—ァセチル ォキシ一 4, 4一ジメチルー 4一フエノキシ一 1ーブチン (47%) を得た。 (3 S) —.3—ヒドロキシ一 4, 4—ジメチル一 4—フエノキシ一 1—ブチン [a] D 23 =— 9. 73° (C= 1.5, メタノール) At (35, 20 hours), (3S) —3-Hydroxy-4,4-dimethyl-41-phenoxy-1-butyne (47%, 87% ee) and (3R) —3-Acetyloxy-1,4,4 One-dimethyl-41-phenoxy-one-butyne (47%) was obtained. (3 S) —.3-hydroxy-1,4,4-dimethyl-1-4-phenoxy-1-butyne [a] D 23 = — 9.73 ° (C = 1.5, methanol)
Ή-NMR (CDC 1 a, 20 OMH z) <5 p pm;  Ή-NMR (CDC 1 a, 20 OMH z) <5 p pm;
1.36(3H, s), 1. 0 (3H, s), 2.29-2.93(1H, br s), 2.49(1H, d, J=2.2Hz), 4.42 (1H, d, J=2.2Hz), 6.80-7.45(5H, m)  1.36 (3H, s), 1.0 (3H, s), 2.29-2.93 (1H, br s), 2.49 (1H, d, J = 2.2Hz), 4.42 (1H, d, J = 2.2Hz), 6.80-7.45 (5H, m)
(3 R) — 3—ァセチルォキシー 4, 4一ジメチルー 4ーフエノキシ— 1—プチ ン  (3 R) — 3-Acetyloxy 4,4-dimethyl 4-phenoxy — 1-Putin
[a] D 23 =— 33. 69° (C = 0. 93, メタノール) [a] D 23 = — 33. 69 ° (C = 0.93, methanol)
(2) 実施例 2の (2) と同様の操作にて (3R) — 3—ヒドロキシ— 4, 4- ジメチルー 4一フエノキシ一 1ーブチン (95%e e) を得た。  (2) By the same operation as (2) in Example 2, (3R) -3-hydroxy-4,4-dimethyl-4-phenoxy-11-butyne (95% ee) was obtained.
[a] D 23=9.81° (C= 1.5, メタノール) [a] D 23 = 9.81 ° (C = 1.5, methanol)
実施例 4  Example 4
(3 R) —、 及び (3 S) — 3—ヒドロキシー 4ーシクロへキシルォキシ— 1 ーブチンの製造法  (3R) —, and (3S) — 3-Hydroxy-4-cyclohexyloxy — 1-butyne
(1) 実施例 1と同様の方法で得られた (3RS) —3—ヒドロキシー 4-シ クロへキシルォキシ一 1ーブチンを用い、 実施例 2の (1) と同様の操作 (35 、 4日間) にて、 (3 S) — 3—ヒドロキシー 4—シクロへキシルォキシ一 1 ーブチン (41 %, 99%e e) 、 及び (3R) — 3—ァセチルォキシ— 4ーシ クロへキシルォキシ— 1ーブチン (41 %) を得た。  (1) The same operation as (1) in Example 2 (35, 4 days) using (3RS) -3-hydroxy-4-cyclohexyloxy-1-butyne obtained in the same manner as in Example 1 (3S) — 3-Hydroxy-4-cyclohexyloxy-1-butyne (41%, 99% ee) and (3R) — 3-Acetyloxy-4-cyclohexyloxy-1butin (41%) I got
(3 S) —3—ヒドロキシ一 4—シクロへキシルォキシ一 1ーブチン  (3 S) —3-Hydroxy-1-4-cyclohexyloxy-1-butyne
[a] 。23= 1 1. 10° (C= 1.28, メタノール) [a]. 23 = 1 1.10 ° (C = 1.28, methanol)
Ή-NMR (CDC 1 a, 20 OMH z) (5 p pm ;  Ή-NMR (CDC 1 a, 20 OMH z) (5 ppm;
1.08-2.1K10H, m), 2.44 (1H, d, J=2.2Hz), 2.60-2.85(1H, br s),  1.08-2.1K10H, m), 2.44 (1H, d, J = 2.2Hz), 2.60-2.85 (1H, br s),
3.26-3.44C1H, m), 3.53C1H, dd, J=7.4, 9.7Hz), 3.66C1H, dd, J=3.7, 9.7Hz), 4.36-4.66(1H, m)  3.26-3.44C1H, m), 3.53C1H, dd, J = 7.4, 9.7Hz), 3.66C1H, dd, J = 3.7, 9.7Hz), 4.36-4.66 (1H, m)
(3 R) — 3—ァセチルォキシ— 4ーシクロへキシルォキシ一 1—ブチン  (3 R) — 3-acetyloxy— 4-cyclohexyloxy 1-butyne
[a] 3 =— 56. 67° (C= 1. 0, メタノール) [a] 3 = — 56. 67 ° (C = 1.0, methanol)
(2) 実施例 2の (2) と同様の操作にて (3R) —3—ヒドロキシー 4ーシ ク口へキシルォキシ一 1—ブチン ( 94 % e e ) を得た。 [a] D 23 =— 1 0. 76° (C= 1. 5, メタノール) 実施例 5 (2) By the same operation as in (2) of Example 2, (3R) -3-hydroxy-4-six-hexoxyl-1-butyne (94% ee) was obtained. [a] D 23 = — 1 0.76 ° (C = 1.5, methanol) Example 5
(3 R) —、 及び (3 S) — 3—ヒドロキシ— 4一へキシルォキシ一 1一プチ ンの製造法  (3R)-, and (3S)-3-Hydroxy- 4-hexyloxy 1-Peptide Production Process
(1) 実施例 1と同様の方法で得られた (3RS) — 3—ヒドロキシ— 4—へ キシルォキシ一 1ーブチンを用い実施例 2の (1) と同様の操作 (35°C、 16 時間) にて、 (3 S) — 3—ヒドロキシー 4一へキシルォキシ一 1ーブチン (2 9 %, 93%e e) 、 及び (3R) — 3—ァセチルォキシー 4ーシクロへキシル ォキシ— 1—ブチン (46%、 60%e e) を得た。  (1) The same operation as (1) in Example 2 (35 ° C, 16 hours) using (3RS) -3-hydroxy-4-hexyloxy-1-butyne obtained by the same method as in Example 1 (3S) —3-hydroxy-4-hexyloxy-1-butyne (29%, 93% ee) and (3R) —3-acetyloxy-4-cyclohexyloxy-1-butyne (46%, 60% % ee).
(3 S) — 3—ヒドロキシー 4一へキシルォキシ一 1ーブチン  (3 S) — 3-Hydroxy 4-hexyloxy 1-butyne
[a] D 23= 1 3. 71° (C= 0. 7◦, メタノール) [a] D 23 = 1 3.71 ° (C = 0.7 °, methanol)
Ή-NMR (CDC 13, 20 OMH z) (5 p p m ;  Ή-NMR (CDC 13, 20 OMH z) (5 p p m;
0.89(3H, t, J=6.4Hz), 1.15-1.77(8H, m), 2.28-2.5K1H, in),  0.89 (3H, t, J = 6.4Hz), 1.15-1.77 (8H, m), 2.28-2.5K1H, in),
' 2.45(1H, d, J=2.2Hz), 3.5K1H, dd, J=9.8, 7.0Hz), 3.53C2H, t, J=6.7Hz), 3.61(1H, dd, J=9.8, 3.8Hz), 4.53(1H, ddd, J=7.0, 3.8, 2.2Hz)  '2.45 (1H, d, J = 2.2Hz), 3.5K1H, dd, J = 9.8, 7.0Hz), 3.53C2H, t, J = 6.7Hz), 3.61 (1H, dd, J = 9.8, 3.8Hz) , 4.53 (1H, ddd, J = 7.0, 3.8, 2.2Hz)
(3 R) 一 3—ァセチルォキシー 4一へキシルォキシ一 1ーブチン  (3 R) 1 3-acetyloxy 4 1-hexyloxy 1 1-butyne
[ ] 。23 =— 42.4 Γ (C= 1. 03, メタノール) 産業上の利用可能拌 []. 23 = — 42.4 Γ (C = 1.03, methanol)
本発明は、 より簡便でより高い光学純度で光学活性プロパルギルアルコール化 合物及びそのァシル化体の製造方法として有用である。 これら光学活性プロパル ギルアルコール化合物及びそのァシル化体は種々の生理活性物質の合成中間体と して重要であるが、 特に医薬品として有用なプロスタグランジン誘導体の ω側鎖 の合成中間体として重要である。  INDUSTRIAL APPLICABILITY The present invention is useful as a simpler method for producing an optically active propargyl alcohol compound having a higher optical purity and an acylated product thereof. These optically active propargyl alcohol compounds and their acylated compounds are important as intermediates for the synthesis of various physiologically active substances, but are particularly important as intermediates for the synthesis of the ω side chain of prostaglandin derivatives useful as pharmaceuticals. is there.

Claims

1. 式 1 set
Figure imgf000011_0001
Figure imgf000011_0001
(式中、 R 1及び R 2はそれぞれ水素原子又は炭素原子数 1 3のアルキル基を示 し、 R 3はフヱニル基、 「炭素原子数 1 5のアルキル基、 ハロゲン原子、 トリフ ルォロメチル基」で任意の位置を置換されたフヱニル基、 炭素原子数 1 8のァ ルキル基又は炭素原子数 5 8のシクロアルキル基を示し、 R 4は炭素原子数 1 10のアルキル基、 フヱニル基、 「フ ニル基又はハロゲン原子」で任意の位置 を置換されたフ 二ル基を示し、 記号 *は光学活性であることを示す。 ) で表さ れる光学活性 0—ァシルプロパルギルアルコール化合物を製造するにあたり、 式 (In the formula, R 1 and R 2 each represent a hydrogen atom or an alkyl group having 13 carbon atoms, and R 3 is a phenyl group, an `` alkyl group having 15 carbon atoms, a halogen atom, or a trifluoromethyl group. '' A phenyl group substituted at any position, an alkyl group having 18 carbon atoms or a cycloalkyl group having 58 carbon atoms, and R 4 is an alkyl group having 1 10 carbon atoms, a phenyl group, or a `` phenyl A halogen or a halogen atom ”, and the symbol * indicates that the compound is optically active. In producing the optically active 0-acylpropargyl alcohol compound represented by the following formula: formula
Figure imgf000011_0002
Figure imgf000011_0002
(式中、 R1 R2及び R3は前記と同意義である。 ) で表される (RS) —プロパ ルギルアルコール化合物を酵素存在下、 R4COOR (式中、 R4は前記と同意義 である。 ) で表されるァシル化剤と反応させることを特徴とする光学活性 0—ァ シルプ °ルギルアルコール化合物の製造方法。 (Wherein R 1 R 2 and R 3 have the same meanings as above.) R 4 COOR (where R 4 is as defined above) in the presence of an enzyme represented by the formula (RS) —propargyl alcohol compound. A process for producing an optically active 0-acylpyrgyl alcohol compound, characterized by reacting with an acylating agent represented by the formula:
2. 式 2. Expression
Figure imgf000011_0003
(式中、 R1友び R2はそれぞれ水素原子又は炭素原子数 1 ~ 3のアルキル基を示 し、 R3はフヱニル基、 「炭素原子数 1〜5のアルキル基、 ハロゲン原子、 トリフ ルォロメチル基」 で任意の位置を置換されたフヱニル基、 炭素原子数 1〜 8のァ ルキル基又は炭素原子数 5〜 8のシク口アルキル基を示し、 記号 *は光学活性で あることを示す。 ) で表される光学活性プロパルギルアルコール化合物を製造す るにあたり、 式
Figure imgf000011_0003
(In the formula, R 1 and R 2 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 3 represents a phenyl group, `` an alkyl group having 1 to 5 carbon atoms, a halogen atom, trifluoromethyl, Represents a phenyl group substituted at any position with a “group”, an alkyl group having 1 to 8 carbon atoms or a cycloalkyl group having 5 to 8 carbon atoms, and the symbol * indicates optical activity.) In producing the optically active propargyl alcohol compound represented by the formula:
Figure imgf000012_0001
Figure imgf000012_0001
(式中、 R R2及び R3は前記と同意義である。 ) で表される (RS) —プロノ、。 ルギルアルコール化合物を酵素存在下、 式 R4 CO OR (式中、 R4は炭素原子数 1〜10のアルキル基、 フヱニル基又は 「フヱニル基又はハロゲン原子」 で任意 の位置を置換されたフヱ二ル基を示し、 Rは任意のアルキル基又はアルケニル基 を示す。 ) で表されるァシル化剤と反応させることにより、 式 (Wherein RR 2 and R 3 have the same meanings as described above.). In the presence of an enzyme, a rugyl alcohol compound is treated with a compound of the formula R 4 CO OR (where R 4 is an alkyl group having 1 to 10 carbon atoms, a phenyl group or a phenyl group or a halogen atom at any position. And R represents any alkyl or alkenyl group.) By reacting with an acylating agent represented by the formula:
Figure imgf000012_0002
Figure imgf000012_0002
(式中、 R'、 R2、 R3、 R 4及び *は前記と同意義である。 ) で表される光学活 性 0—ァシルプロパルギルアルコール化合物を立体選択的に得、 次いで::れを分 離後加水分解することを特徴とする光学活性プロ '、°ルギルァルコール化合物の製 造方法。 (Wherein R ′, R 2 , R 3 , R 4 and * are as defined above.) Stereoselectively obtain an optically active 0-acylpropargyl alcohol compound represented by the formula: A method for producing an optically active pro- and lugyl alcohol compound, characterized in that it is hydrolyzed after separation.
3. 式 3. Expression
Figure imgf000013_0001
Figure imgf000013_0001
(式中、 R 1及び R2はそれぞれ水素原子又は炭素原子数 1〜 3のアルキル基を示 し、 R 3はフヱニル基、 「炭素原子数 1 5のアルキル基、 ハロゲン原子、 トリフ ルォロメチル基」で任意の位置を置換されたフエニル基、 炭素原子数 1 8のァ ルキル基又は炭素原子数 5 8のシクロアルキノレ基を示し、 記号 *は光学活性で あることを示す。 ) で表される光学活性プロパルギルアルコーノレ化合物を製造す るにあたり、 式 (Wherein, R 1 and R 2 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and R 3 represents a phenyl group, a `` alkyl group having 15 carbon atoms, a halogen atom, or a trifluoromethyl group '' Represents a phenyl group substituted at any position, an alkyl group having 18 carbon atoms or a cycloalkynole group having 58 carbon atoms, and the symbol * indicates that the compound is optically active. In producing the propargyl alcohol compound, the formula
Figure imgf000013_0002
Figure imgf000013_0002
(式中、 R R2及び R3は前記と同意義である。 ) で表される (RS) —プ ルギルアルコール化合物を酵素存在下、 式 R4COOR (式中、 R 4は炭素原子数 1 10のアルキル基、 フエ二ル基、 「フヱニル基又はハロゲン原ネ _]で任意の 位置を置換されたフヱニル基を示し、 Rは任意のアルキル基又はアルケニル基を 示す。 )で表されるァシル化剤と反応させた溶液より分離することを特徴とする 光学活性プ 、。ルギルアルコ ル化合物の製造方法。 (Wherein RR 2 and R 3 have the same meanings as described above.) A compound represented by the formula (RS) —Pulgyl alcohol compound is prepared in the presence of an enzyme by the formula R 4 COOR (where R 4 is the number of carbon atoms) 110 represents an alkyl group, a phenyl group, a phenyl group or a phenyl group substituted at any position with a halogen atom, and R represents an arbitrary alkyl group or an alkenyl group. An optically active compound, which is separated from a solution reacted with an acylating agent.
4. 酵素がシ ドモナス属に属する微生物が生産する酵素である請求の範囲 1 3の 、ずれかに記載の製造方法。 4. The production method according to claim 13, wherein the enzyme is an enzyme produced by a microorganism belonging to the genus Sydmonas.
5. ァシル化剤がィソプロべニルァセテ一トである請求の範囲 1 3のいずれ かに記載の製造方法。 5. The production method according to claim 13, wherein the acylating agent is isoproenyl acetate.
PCT/JP1995/001064 1994-06-02 1995-05-31 Process for producing optically active propargyl alcohol compound WO1995033845A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25752/95A AU2575295A (en) 1994-06-02 1995-05-31 Process for producing optically active propargyl alcohol compound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12145994 1994-06-02
JP6/121459 1994-06-02

Publications (1)

Publication Number Publication Date
WO1995033845A1 true WO1995033845A1 (en) 1995-12-14

Family

ID=14811664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1995/001064 WO1995033845A1 (en) 1994-06-02 1995-05-31 Process for producing optically active propargyl alcohol compound

Country Status (2)

Country Link
AU (1) AU2575295A (en)
WO (1) WO1995033845A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061777A1 (en) * 1999-04-12 2000-10-19 Chirotech Technology Limited Process for the preparation of prostaglandin precursors
US6214611B1 (en) 1999-04-12 2001-04-10 Chirotech Technology Limited Process for the preparation of prostaglandin precursors
WO2006076565A3 (en) * 2005-01-14 2006-12-07 Schering Corp Preparation of chiral propargylic alcohol and ester intermediates of himbacine analogs
US7897795B2 (en) 2008-04-09 2011-03-01 Scinopharm Taiwan Ltd. Process for the preparation of prostaglandin analogues and intermediates thereof
CN103917665A (en) * 2011-11-09 2014-07-09 纳幕尔杜邦公司 Sequences and their use for detection of salmonella
WO2020255164A1 (en) * 2019-06-21 2020-12-24 Council Of Scientific And Industrial Research A chemo-enzymatic process for the preparation of homopropargylic alcohol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01171497A (en) * 1987-12-26 1989-07-06 Lion Corp Optical resolution of racemic alcohol
JPH02262536A (en) * 1989-04-01 1990-10-25 Arakawa Chem Ind Co Ltd Optically active compound and its production
JPH03210194A (en) * 1990-01-11 1991-09-13 Konica Corp Multilayer analytical element

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01171497A (en) * 1987-12-26 1989-07-06 Lion Corp Optical resolution of racemic alcohol
JPH02262536A (en) * 1989-04-01 1990-10-25 Arakawa Chem Ind Co Ltd Optically active compound and its production
JPH03210194A (en) * 1990-01-11 1991-09-13 Konica Corp Multilayer analytical element

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061777A1 (en) * 1999-04-12 2000-10-19 Chirotech Technology Limited Process for the preparation of prostaglandin precursors
US6214611B1 (en) 1999-04-12 2001-04-10 Chirotech Technology Limited Process for the preparation of prostaglandin precursors
JP2002541816A (en) * 1999-04-12 2002-12-10 カイロテック・テクノロジー・リミテッド Method for the preparation of prostaglandin precursor
WO2006076565A3 (en) * 2005-01-14 2006-12-07 Schering Corp Preparation of chiral propargylic alcohol and ester intermediates of himbacine analogs
US7897795B2 (en) 2008-04-09 2011-03-01 Scinopharm Taiwan Ltd. Process for the preparation of prostaglandin analogues and intermediates thereof
US8436194B2 (en) 2008-04-09 2013-05-07 Scinopharm Taiwan, Ltd. Process for the preparation of prostaglandin analogues and intermediates thereof
US8742143B2 (en) 2008-04-09 2014-06-03 Scinopharm Taiwan, Ltd. Process for the preparation of prostaglandin analogues
CN103917665A (en) * 2011-11-09 2014-07-09 纳幕尔杜邦公司 Sequences and their use for detection of salmonella
CN103917665B (en) * 2011-11-09 2016-11-16 纳幕尔杜邦公司 Sequence and their usage for Salmeterol fluticasone propionate
WO2020255164A1 (en) * 2019-06-21 2020-12-24 Council Of Scientific And Industrial Research A chemo-enzymatic process for the preparation of homopropargylic alcohol
US12247239B2 (en) 2019-06-21 2025-03-11 Council Of Scientific & Industrial Research Chemo-enzymatic process for the preparation of homopropargylic alcohol

Also Published As

Publication number Publication date
AU2575295A (en) 1996-01-04

Similar Documents

Publication Publication Date Title
JP3789938B2 (en) Racemic resolution of primary and secondary heteroatom-substituted amines by enzyme-catalyzed acylation
US4946999A (en) Novel intermediates for synthesis of trichostatic acid or trichostatin A, and processes for preparing trichostatic acid and trichostatin A
EP0385733B1 (en) Process for preparing optically active 6-t-butoxy-3,5-dihydroxyhexanoic esters
JPH05331128A (en) @(3754/24)r)-@(3754/24)-)-4-cyano-3-hydroxylactic acid t-butyl ester and its production
KR19980701944A (en) How to separate carbinol
JP3351563B2 (en) Method for producing 3-hydroxybutyric acid derivative
WO1995033845A1 (en) Process for producing optically active propargyl alcohol compound
JPH1057094A (en) Enzymatic optical resolution of alcohol using ketene acetal type acylating agent
JP2003512034A (en) Method for producing chiral ester
JPH06256278A (en) Optically active alpha-carbamoylalkanoic acid derivative and its production
JP2709807B2 (en) Process for producing 3-chloro-4-silyloxy-2-cyclopenten-1-ones
US5442105A (en) Process for producing cyclohexylbutyric acid derivative
JP2594605B2 (en) Optically active α, α-difluoro-β-hydroxycarbonyl compound
JP3121656B2 (en) Optically active glycidol derivative and method for producing the same
WO1994000593A1 (en) Process for the preparation of substituted and optically pure 1-arylalkanols
KR100650797B1 (en) Method for preparing optically active cyclopropane carboxamide
JP2627507B2 (en) Cis-3-chloro-4-silyloxy-2-cyclopenten-1-ols and their production
JP3660385B2 (en) Process for producing optically active allophenylnorstatin derivative
KR100752282B1 (en) Method for preparing 2-chlorostyrene oxide of (R)-or (S) -form using enzyme
JP3620872B2 (en) Process for producing optically active 1-ferrocenyl-2,2,2-trifluoroethanol derivative and novel 1-ferrocenyl-2,2,2-trifluoroethylcarboxylate compound
JPH0847398A (en) Process for producing optically active propargyl alcohol compound
JPH0249742A (en) Optically active fluorine-containing α-hydroxycyclopropane compound
JP3060915B2 (en) trans-3-hydroxy-4-phenylthiotetrahydrofuran and process for producing the same
JPH05284986A (en) Production of optically active 1,4-dihydropyridine compound
JPH04279566A (en) 1,4-dihydropyridine derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载